Michael Broxson, Founder of Q32 Bio

Michael Broxson is the founder of Q32 Bio. Q32 Bio has raised $60M in total funding. Latest round: Series B. Based in Cambridge, USA.

About Michael Broxson

Michael Broxson was the CEO of Q32 Bio, a biotechnology company developing biologic therapeutics to restore healthy immune regulation. During his tenure, he oversaw the company's progression to a clinical-stage company with two rapidly advancing clinical programs: ADX-914, an anti-IL-7R\u03b1 antibody, and ADX-097, a tissue-targeted protein therapeutic. Q32 Bio completed a $60 million Series B financing round under his leadership.

Michael Broxson at a glance

More founders in Cambridge, USA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library